![](https://web.genewiz.com/hubfs/Predeveloped-Assays_LP-Hero-Med%20(1).png)
GENEWIZ Multiomics & Synthesis Solutions from Azenta Life Sciences offers a wide range of predeveloped assays – your express route to cutting-edge research in oncology, neurological disorders, and more. Unlock the power of off-the-shelf assays, including key targets like BRCA1/2, TP53, HTT, and FOXP2. Collaborate with our adept scientists, submit samples via convenient drop boxes, and receive rapid results to elevate your research with precision, minus the hassle.
![](https://web.genewiz.com/hubfs/Transition_Purple-Checkmark.png)
Various sample types accepted, including cell, tissue, FFPE, gDNA, RNA, and more
![](https://web.genewiz.com/hubfs/Transition_Purple-Checkmark.png)
Industry-leading customer support, including weekly project updates
![](https://web.genewiz.com/hubfs/Transition_Purple-Checkmark.png)
Data delivery starting at just 3 business days after assay development
FEATURED PREDEVELOPED ASSAYS
Please contact our Customer Support for additional genes. New assay development may require an additional 5 days.
See Full List of Assays
Filter Table
GENE ID | Gene Name | Primary Panel | Details/Secondary Panel Opportunities |
BRCA2 | Breast Cancer 2, Early Onset | Pan-Cancer | Hereditary Breast Cancer, solid tumors, oncology |
HRAS | Harvey Rat Sarcoma Viral Oncogene Homolog | Pan-Cancer | HRAS signaling, MAPK signaling, oncology |
IDH1 | Isocitrate Dehydrogenase 1 | Pan-Cancer | Cellular metabolism, oncology |
IDH2 | Isocitrate Dehydrogenase 2 | Pan-Cancer | Cellular metabolism, oncology |
IDH3 | Isocitrate Dehydrogenase 3 | Pan-Cancer | Cellular metabolism, oncology |
IDH4 | Isocitrate Dehydrogenase 4 | Pan-Cancer | Cellular metabolism, oncology |
IDH5 | Isocitrate Dehydrogenase 5 | Pan-Cancer | Cellular metabolism, oncology |
IDH6 | Isocitrate Dehydrogenase 6 | Pan-Cancer | Cellular metabolism, oncology |
IDH7 | Isocitrate Dehydrogenase 7 | Pan-Cancer | Cellular metabolism, oncology |
IDH8 | Isocitrate Dehydrogenase 8 | Pan-Cancer | Cellular metabolism, oncology |
KRAS | Kirsten Rat Sarcoma Viral Oncogene Homolog | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
MAP2K1 | Mitogen-Activated Protein Kinase Kinase 1 | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
MAP2K2 | Mitogen-Activated Protein Kinase Kinase 2 | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
MAPK1 | Mitogen-Activated Protein Kinase 1 | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
NRAS | Neuroblastoma RAS Viral Oncogene Homolog | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
PIK3CA | Phosphatidylinositol-4,5-Bisphosphate 3-Kinase | Pan-Cancer | PI3K signaling, mTor signaling, solid tumors, oncology |
PTEN | Phosphatase and Tensin Homolog | Pan-Cancer | Tumor suppressor, solid tumors, oncology |
p53 | Tumor Protein p53 | Pan-Cancer | Oncology |
APOE | Apolipoprotein E | Neuropathology | Alzheimer's disease, dementia, neuropathology |
EGFR | Epidermal Growth Factor Receptor | Pan-Cancer | Oncology, lung cancers, solid tumors |
TNF | Tumor Necrosis Factor | Pan-Cancer | Immunology, IBD, autoimmune disorders, oncology |
IL6 | Interleukin-6 | Auto-immune | Autoimmune disorders, arthritis |
COL1A2 | Collagen type 1 alpha 2 chain | Pan-cancer | Tumorigenesis, oncology, connective tissue disorders |
PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | Pan-cancer | Alzheimer's disease, dementia, neuropathy, oncology |
USMG5 | AKA ATP5MK; ATP synthase membrane subunit k | Auto-immune | Diabetes |
ATP13A3 | ATPase 13A3 | Pan-Cancer | Oncology, polyamine trafficking, pancreatic cancer |
SERPINA1 | Serpin family A member 1 | Auto-immune | Liver disease |
GJB2 | Gap junction protein beta 2 | Neuropathy | Hearing loss, neuropathy |
TRIM62 | Tripartite motif containing 62 | Auto-immune | Innate immune response, autoimmune disorders |
CARD9 | Caspase recruitment domain family member 9 | Auto-immune | Innate immune response, autoimmune disorders |
JAG1 | Jagged canonical Notch ligand 1 | Pan-Cancer | Notch signaling, developmental disorders, oncology |
BRAF | B-Raf proto-oncogene, serine/threonine kinase | Pan-Cancer | MAPK signaling, oncology |